Trial Profile
Immunogenicity of influenza vaccination among breast cancer patients treated with trastuzumab in adjuvant setting
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Sep 2016
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Trastuzumab
- Indications Breast cancer
- Focus Pharmacodynamics
- 16 Sep 2016 New trial record